‡ In these countries please contact our distributor


Infection can stall the healing process1

High bioburden/wound infection can lead to a prolonged inflammation in a wound creating a cycle of inflammation  and tissue damage, subsequently the wound enters chronic state and fails to heal1,2

IODOSORB and IODOFLEX reduce bioburden3-8

  • Provides broad-spectrum antimicrobial activity for up to 72 hours (in vitro)3
  • Reduction in wound bioburden 4-7and infection4-6
  • Controlled release of Cadexomer Iodine 0.9% concentration: effective, sustained antimicrobial activity8 and reduced toxicity9

Evidence: IODOSORB against bioburden and infection 


1. Edwards R and Harding KG. Curr Opin. Infect. Dis. 17, 91–96 (2004).
2. Menke NB, et al. Clin. Dermatol. 25, 19–25 (2007);
3. Salman H, Leakey A. Report number 194-03-01 (2001)
4. Sundberg J, Meller R. Wounds. 9:68-86 (1997).
5. Ormiston MC, Seymour MTJ, Venn GE, et al., In: Fox JA, Fischer H, eds. Cadexomer Iodine. New York, NY: F.K. Schattauer Verlag; 63-69 (1983).
6. Skog E, Arnesjo B, Troeng T, et al., Br J Dermatol.109:77-83.(1983).
7. Schwartz, J. a et al., Int. Wound J. 10, 193–9 (2013).
8. Harrow, J. 6763/IODOSORB/TECHMON/GLOBAL/0404. (2009). 
9. Zhou LH, et al., Br. J. Dermatol. 146, 365–74. (2002).
10. Danielsen L, et al. J Wound Care 1997; 6(4):169-172.
11. Johnson A. Professional Nurse, 1991. October: 60-64.
12. Lindsay G, et al. Acta Therapeutica 1986;12:141-148.
13. Hilstrom L. Acta Chir Scan Suppl, 1988. 544:53-56.
14. Miller CN, et al. Wound Repair Regen. 2010;18:359–67.
15. Moss C, et al. Clin Exp Dermatol 1987;12(6):413-8.

Learn more about the barriers to healing

Learn more >>